ADVERTISEMENT
search.svg

Pharmacy News

Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes

Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults. Recent studies have estimated that approximately 36% of older adults take at least 5 prescription medications, and 67% take 5 or more medications or supplements, including OTCs.

ISMP issues warning about possible safety issues with newly authorized antiviral

To encourage the appropriate use of Pfizer’s COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid), the Institute for Safe Medication Practices (ISMP) released an alert for dispensing pharmacists.

CDC releases guidance on caring for ‘COVID long-haulers’

Thousands of patients have reported experiencing a wide range of physical and mental health consequences that persist after a COVID-19 infection. Patients with post-COVID-19 conditions, sometimes referred to as “COVID long-haulers,” often experience issues four or more weeks after being infected with the virus. Many of these patients routinely seek medical treatment for relief of their symptoms.

What might this flu season have in store?

Influenza cases and deaths in the United States and worldwide dropped to unprecedented lows between October 3, 2020, and July 24, 2021, according to CDC data. In a typical season, 75 to 150 children die of influenza in the United States, noted pediatric infectious disease specialist Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia, in a recent JAMA Network article. Last influenza season, he said, one child was reported to have died.

Flu vaccine can protect against severe effects of COVID-19, study finds

A new study published in PLoS One suggests that the influenza vaccine may help safeguard individuals against COVID-19.

RSS
123